Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Psychiatric comorbidity in multiple sclerosis: It's not the genes.
Neurofascin 140 is an embryonic neuronal neurofascin isoform that promotes the assembly of the node of ranvier.
MS susceptibility is not affected by single nucleotide polymorphisms in the MMP9 gene.
[Stem cell transplantation for multiple sclerosis : Hamburg experiences and state of international research].
Cognitive motor interference during walking in multiple sclerosis using an alternate letter alphabet task.
[Driving ability with multiple sclerosis.]
[Regarding the article: "multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort"].
Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
Subacute sclerosing panencephalitis presenting as neuromyelitis optica.
Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?
RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease?
The role of chromogranin B in an animal model of multiple sclerosis.
Modelling the Cost Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis : Issues to Consider.
Safety and efficacy of natalizumab in children with multiple sclerosis.
Increasing the Contrast of the Brain MR FLAIR Images Using Fuzzy Membership Functions and Structural Similarity Indices in Order to Segment MS Lesions.
Reduced field-of-view DTI segmentation of cervical spine tissue.
Is it time to revise the classification of geographical distribution of multiple sclerosis?
Lower Serum Levels of Th2-Related Chemokine CCL22 in Women Patients with Multiple Sclerosis: A Comparison Between Patients and Healthy Women.
Microglial Voltage-Gated Proton Channel Hv1 in Ischemic Stroke.
Interaction between passive smoking and two HLA genes with regard to multiple sclerosis risk.
ANALYSIS OF MULTIPLE SCLEROSIS LESIONS VIA SPATIALLY VARYING COEFFICIENTS.
High-resolution melting analysis for mutation scanning in the non-coding control region of JC polyomavirus from patients with progressive multifocal leukoencephalopathy.
NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis.
Oligodendrocytes in a Nutshell.
Use of a physiological profile to document motor impairment in ageing and in clinical groups.
Pages
« first
‹ previous
…
455
456
457
458
459
460
461
462
463
…
next ›
last »